Drugs@FDA document
FLONASE Review · NDA 020121 SUPPL-5
Drugs@FDA document · HALEON US HOLDINGS · May 25, 2010
Key facts
| Drug name | FLONASE |
|---|---|
| Document type | Review |
| Application | NDA020121 |
| Submission | SUPPL-5 |
| Company | HALEON US HOLDINGS |
| Document date | May 25, 2010 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-New Indication Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: